Task: Answer the multiple-choice question.
Query: Which drug has a 2.785% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a. COc1ccc(-n2c(SCC(=O)NC3CC3)nc3ccccc3c2=O)cc1OC
b. CC(C)Cn1c(N)c(C(=O)COC(=O)c2cc(-c3ccccc3)nc3ccccc23)c(=O)n(C)c1=O
Answer: a. COc1ccc(-n2c(SCC(=O)NC3CC3)nc3ccccc3c2=O)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(-n2c(SCC(=O)NC3CC3)nc3ccccc3c2=O)cc1OC
COc1ccc(-n2c(SCC(=O)NC3CC3)nc3ccccc3c2=O)cc1OC
N-cyclopropyl-2-[3-(3,4-dimethoxyphenyl)-4-oxoquinazolin-2-yl]sulfanylacetamide